Arthur A Levin's Net Worth
$10.1 Million
Who is Arthur A Levin?
Arthur A Levin has an estimated net worth of $10.1 Million. This is based on reported shares across multiple companies, which include Stoke Therapeutics, Inc., Avidity Biosciences, Inc., and ISIS PHARMACEUTICALS INC.
SEC CIK
Arthur A Levin's CIK is 0001181556
Past Insider Trading and Trends
2021 was Arthur A Levin's most active year for acquiring shares with 14 total transactions. Arthur A Levin's most active month to acquire stocks was the month of December. 2006 was Arthur A Levin's most active year for disposing of shares, totalling 37 transactions. Arthur A Levin's most active month to dispose stocks was the month of February. 2006 saw Arthur A Levin paying a total of $586,237.30 for 122,897 shares, this is the most they've acquired in one year. In 2022 Arthur A Levin cashed out on 240,000 shares for a total of $2,648,234.48, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Stoke Therapeutics, Inc. (STOK) Snapshot price: $4.71
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
$30.66 | -$753,264.74 |
0
|
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Avidity Biosciences, Inc. (RNA) Snapshot price: $12.18
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$23.13 | -$218,869.00 | 14.83K |
Scheduled
|
Jul 19
| ||
Form 4
|
—
|
0
|
$19.42 | -$181,750.50 | 14.83K |
Scheduled
|
Jun 20
| ||
Form 4
| -39.39% | -100.00K |
$38.07 | -$3,807,410.00 | 153.87K |
Scheduled
|
Jun 12 - Jun 13
| ||
Form 4
|
—
|
0
|
$15.57 | -$143,281.00 | 14.83K |
Scheduled
|
May 20
| ||
Form 4
|
—
|
0
|
$12.03 | -$107,923.00 | 14.83K |
Scheduled
|
Apr 19
| ||
Form 4
| -7.30% | -20.00K |
$27.11 | -$542,214.00 | 253.87K |
Scheduled
|
Apr 3
| ||
Form 4
|
—
|
0
|
$12.60 | -$113,647.50 | 14.83K |
Scheduled
|
Mar 19
| ||
Form 4
| -15.12% | -2.64K |
$11.64 | -$578,017.00 | 14.83K |
Scheduled
|
Mar 12
| ||
Form 4
| -9.62% | -1.86K |
$10.13 | -$18,831.67 | 17.47K |
Scheduled
|
Jan 22
| ||
Form 4
|
—
|
0
|
$11.63 | -$2,077.00 | 19.33K |
Scheduled
|
Mar 15
| ||
Form 4
|
—
|
0
|
$12.45 | -$224,166.86 | 19.33K |
Scheduled
|
Feb 14
| ||
Form 4
| +1,353.38% | 18K |
—
|
—
| 19.33K |
Jan 20
| |||
Form 4
|
—
|
0
|
$11.62 | -$207,628.00 | 1.33K |
Scheduled
|
Jan 12
| ||
Form 4
|
—
|
0
|
$11.63 | -$830,968.00 | 1.33K |
Scheduled
|
Dec 29
| ||
Form 4
|
—
|
0
|
$11.49 | -$1,698,104.01 | 1.33K |
Scheduled
|
Aug 12 - Aug 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
—
|
0
|
$14.56 | -$666,646.34 | 1.33K |
Scheduled
|
Nov 18
| ||
Form 4
|
—
|
0
|
$14.63 | -$545,215.13 | 1.33K |
Scheduled
|
Jun 24 - Jun 25
| ||
Form 4
|
—
|
0
|
$14.50 | -$5,302.00 | 1.33K |
Scheduled
|
Jun 17
| ||
Form 4
| -100.00% | -37.02K |
$25.98 | -$961,988.53 |
0
|
Jun 14 - Jun 15
| |||
Form 4
|
—
|
0
|
$14.41 | -$123,879.55 | 310.89K |
Scheduled
|
Mar 5 - Mar 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
| +5.69% | 16.75K |
—
|
—
| 310.89K |
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ISIS PHARMACEUTICALS INC (IONS) Snapshot price: $49
Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$7.68 | -$29,160.00 | 1.67K |
Scheduled
|
Apr 25
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
$9.44 | -$262,900.00 | 1.67K |
Scheduled
|
Nov 9 - Nov 13
| ||
Form 4
|
—
|
0
|
$7.32 | -$41,145.12 | 1.67K |
Scheduled
|
Oct 19
| ||
Form 4
|
—
|
0
|
$6.56 | -$28,236.23 | 1.67K |
Scheduled
|
Oct 6
| ||
Form 4
|
—
|
0
|
$7.94 | -$21,972.76 | 1.67K |
Scheduled
|
Mar 20 - Mar 21
| ||
Form 4
|
—
|
0
|
$6.59 | -$22,377.60 | 1.67K |
Scheduled
|
Feb 17
| ||
Form 4
|
—
|
0
|
$6.55 | -$8,400.00 | 1.67K |
Scheduled
|
Feb 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +12.20% | 182 |
$4.67 | $849.30 | 1.67K |
Jan 1 - Jan 3
| |||
Form 4
|
—
|
0
|
$6.04 | -$325.00 | 1.49K |
Scheduled
|
Dec 22
| ||
Form 4/A
|
—
|
0
|
$6.03 | -$2,522.50 | 1.49K |
Scheduled
|
Dec 9 - Dec 10
| ||
Form 4
|
—
|
0
|
$6.03 | -$1,697.50 | 1.49K |
Scheduled
|
Dec 10
| ||
Form 4
|
—
|
0
|
$6.10 | -$2,129.11 | 1.49K |
Scheduled
|
Dec 3
| ||
Form 4
| +22.30% | 272 |
$4.86 | $1,322.46 | 1.49K |
Jul 1
| |||
Form 4
| +56.81% | 442 |
$4.46 | $1,972.43 | 1.22K |
Jan 1 - Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||